[1]
“ASSESSING THE IMPACT OF PHARMACOGENOMICS ON DRUG PRESCRIBING PATTERNS IN CHRONIC DISEASE MANAGEMENT”, JMHSR, vol. 2, no. 2, May 2025, doi: 10.62019/xtdsr651.